HUBUNGAN LAMA IMPLANTASI STENT DENGAN KEJADIAN IN-STENT RESTENOSIS BERMAKNA PADA PASIEN PJK YANG DILAKUKAN ANGIOGRAFI KORONER EVALUASI DI RUMAH SAKIT UMUM DAERAH PROVINSI NUSA TENGGARA BARAT
DOI:
https://doi.org/10.29303/jku.v10i1.477Kata Kunci:
in-stent restenosis, lama implantasi stent, angiografi koroner evaluasi, penyakit jantung koronerAbstrak
Latar belakang : Kejadian in-stent restenosis merupakan suatu permasalahan yang terjadi pada pasien yang telah menjalankan prosedur intervensi koroner perkutan. Penelitian ini bertujuan untuk mengetahui hubungan antara lama implantasi stent dengan kejadian in-stent restenosis bermakna pada pasien penyakit jantung koroner (PJK) yang dilakukan angiografi koroner evaluasi.
Metode : Penelitian ini merupakan penelitian analitik observasional dengan metode potong lintang pada pasien PJK yang dilakukan angiografi koroner evaluasi di Rumah Sakit Umum Daerah Provinsi Nusa Tenggara Barat. Data diperoleh dari data laboratorium kateterisasi jantung dan rekam medis pasien pada periode Januari 2018 hingga Juni 2020. Analisis dilakukan dengan uji hipotesis korelatif eta dengan aplikasi statistik SPSS Ver. 26.0
Hasil : Total subjek penelitian berjumlah 89 subjek. Hasil analisis statistik menunjukkan nilai p = 0,174 dan r = 0,251.
Kesimpulan : Tidak terdapat hubungan antara lama implantasi stent dengan kejadian in-stent restenosis bermakna pada pasien PJK yang dilakukan angiografi koroner evaluasi di Rumah Sakit Umum Daerah Provinsi Nusa Tenggara Barat.
Kata kunci : In-stent restenosis, lama implantasi stent, angiografi koroner evaluasi, penyakit jantung koroner
Referensi
1. Institute for Health Metrics and Evaluation. Global Burden of Disease Study 2017. 2017.
2. World Health Organization (WHO). Cardiovascular diseases ( CVDs ) [Internet]. World Health Organization. 2017. Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
3. Kementerian Kesehatan BL. Situasi Kesehatan Jantung. 2014.
4. Cheng G, Chang FJ, Wang Y, You PH, Chen HC, Han WQ, et al. Factors influencing stent restenosis after percutaneous coronary intervention in patients with coronary heart disease: A clinical trial based on 1-year follow-up. Med Sci Monit. 2019;25:240–7.
5. Jukema JW, Verschuren JJW, Ahmed TAN, Quax PHA. Restenosis after PCI. Part 1: Pathophysiology and risk factors. Nat Rev Cardiol [Internet]. 2012;9(1):53–62. Available from: http://dx.doi.org/10.1038/nrcardio.2011.132
6. Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in-stent restenosis: A review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016;8(10):E1150–62.
7. Her A, Shin E. Current Management of In-Stent Restenosis. Korean Circ J. 2018;48(5):337–49.
8. Lee MS, Banka G. In-stent Restenosis. Interv Cardiol Clin [Internet]. 2015;5(2):211–20. Available from: http://dx.doi.org/10.1016/j.iccl.2015.12.006
9. Sajadian M, Alizadeh L, Ganjifard M, Mardani A, Ansari MA, Falsoleiman H. Factors Affecting In-stent Restenosis in Patients Undergoing Percutaneous Coronary Angioplasty GMJ. Gmj [Internet]. 2018;7:961. Available from: www.gmj.irhttp://creativecommons.org/licenses/by/4.0/
10. Marino BCA, Nascimento GA, Rabelo W, Marino MA, Marino RL, Ribeiro ALP. Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes. Arq Bras Cardiol. 2015;104(5):375–86.
11. Kang SJ, Mintz GS, Park DW, Lee SW, Kim YH, Lee CW, et al. Mechanisms of in-stent restenosis after drug-eluting stent implantation intravascular ultrasound analysis. Circ Cardiovasc Interv. 2011;4(1):9–14.
12. Mitra AK, Agrawal DK. In stent Restenosis: Bane of the Stent Era. J Clin Pathol. 2006;59(3):232–9.
13. Maas AHEM, Appelman YEA. Gender differences in coronary heart disease. Netherlands Hear J. 2010;18(12):598–603.
14. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):1–12.
15. Pathak LA, Shirodkar S, Ruparelia R, Rajebahadur J. Coronary artery disease in women. Indian Heart J [Internet]. 2017;69(4):532–8. Available from: http://dx.doi.org/10.1016/j.ihj.2017.05.023
16. Eugenmed T, Clinical C, Group S, Regitz-zagrosek V, Oertelt-prigione S, Prescott E, et al. Gender in cardiovascular diseases?: impact on clinical manifestations , management , and outcomes. 2016;24–34.
17. Ashley E, Niebaur J. Coronary artery disease. In: Cardiology Explained. 2004.
18. Dhingra R, Vasan RS. Age As a Risk Factor. Med Clin North Am. 2012;96(1):87–91.
19. North BJ, Sinclair DA. The Intersection Between Aging and Cardiovascular Disease. Circ Res. 2012;110(8):1097–108.
20. Brown JC, Gerhardt TE, Kwon E. Risk Factors for Coronary Artery Disease. Statpearls. 2020;
21. Hussain MA, Mamun A Al, Peters SAE, Woodward M, Huxley RR. The burden of cardiovascular disease attributable to major modifiable risk factors in Indonesia. J Epidemiol. 2016;26(10):515–21.
22. Maharani A, Sujarwoto, Praveen D, Oceandy D, Tampubolon G, Patel A. Cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in Indonesia: The SMARThealth Extend study. PLoS One. 2019;14(4):1–13.
23. Kapoor R, Vyas S, Patel P, Mehta H, Mehta P, Modi J, et al. Short Communication A case-control study of risk factors for ischemic heart disease in patients attending tertiary care hospitals in India. 2013;3(1):57–60.
24. Djafri D, Monalisa, Elytha F, Machmud R. Efek modifikasi faktor risiko modifiable penyakit jantung koroner: a hospital-based matched case control study. J Kesehat Masy Andalas. 2017;11(2):93–9.
25. Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246.
26. Mazin I, Paul G, Asher E. Neoatherosclerosis – From basic concept to clinical implication. Thromb Res [Internet]. 2019;178(July 2018):12–6. Available from: https://doi.org/10.1016/j.thromres.2019.03.016
27. Bhatt DL. Percutaneous coronary intervention in 2018. JAMA - J Am Med Assoc. 2018;319(20):2127–8.
28. Mehilli J, Kastrati A, Bollwein H, Dibra A, Schühlen H, Dirschinger J, et al. Gender and restenosis after coronary artery stenting. Eur Heart J. 2003;24(16):1523–30.
29. Yamaji K, Shiomi H, Morimoto T, Toyota T, Ono K, Furukawa Y, et al. Influence of sex on long-term outcomes after implantation of bare-metal stent a multicenter report from the coronary revascularization demonstrating outcome study-kyoto (CREDO-Kyoto) registry cohort-1. Circulation. 2015;132(24):2323–33.
30. Regueiro A, Fernández-Rodríguez D, Brugaletta S, Martín-Yuste V, Masotti M, Freixa X, et al. Sex-related Impact on Clinical Outcome of Everolimus-eluting Versus Bare-metal Stents in ST-segment Myocardial Infarction. Insights From the EXAMINATION Trial. Rev Española Cardiol (English Ed. 2015;68(5):382–9.
31. Cho JY. Identification of Risk Factors Influencing In-Stent Restenosis with Acute Coronary Syndrome Presentation. Chonnam Med J. 2017;53(3):203.
32. Tang L, Cui QW, Liu DP, Fu YY. The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention. Med (United States). 2019;98(50):1–7.
33. Mohan S, Dhall A. A comparative study of restenosis rates in bare metal and drug-eluting stents. Int J Angiol. 2010;19(2).
34. Ogobuiro I, Wehrle CJ, Tuma F. Anatomy , Thorax , Heart Pulmonary Arteries Blood Supply and Lymphatics. Statpearls. 2020.
35. Weber C, Brown KN, Borger J. Anatomy, Thorax, Heart Anomalous Left Anterior Descending (LAD) Artery [Internet]. StatPearls. 2020. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30844189
36. Wihanda D, Alwi I, Yamin M, Shatri H, Mudjaddid E. Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention. Acta Med Indones. 2015;47(3):209–15.
37. Calais F, Lagerqvist B, Leppert J, James SK, Fröbert O. Proximal coronary artery intervention: Stent thrombosis, restenosis and death. Int J Cardiol [Internet]. 2013;170(2):227–32. Available from: http://dx.doi.org/10.1016/j.ijcard.2013.10.060
38. Schmidt W, Lanzer P, Behrens P, Brandt-Wunderlich C, Öner A, Ince H, et al. Direct comparison of coronary bare metal vs. drug-eluting stents: Same platform, different mechanics? Eur J Med Res [Internet]. 2018;23(1):1–12. Available from: https://doi.org/10.1186/s40001-017-0300-y
2. World Health Organization (WHO). Cardiovascular diseases ( CVDs ) [Internet]. World Health Organization. 2017. Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
3. Kementerian Kesehatan BL. Situasi Kesehatan Jantung. 2014.
4. Cheng G, Chang FJ, Wang Y, You PH, Chen HC, Han WQ, et al. Factors influencing stent restenosis after percutaneous coronary intervention in patients with coronary heart disease: A clinical trial based on 1-year follow-up. Med Sci Monit. 2019;25:240–7.
5. Jukema JW, Verschuren JJW, Ahmed TAN, Quax PHA. Restenosis after PCI. Part 1: Pathophysiology and risk factors. Nat Rev Cardiol [Internet]. 2012;9(1):53–62. Available from: http://dx.doi.org/10.1038/nrcardio.2011.132
6. Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in-stent restenosis: A review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016;8(10):E1150–62.
7. Her A, Shin E. Current Management of In-Stent Restenosis. Korean Circ J. 2018;48(5):337–49.
8. Lee MS, Banka G. In-stent Restenosis. Interv Cardiol Clin [Internet]. 2015;5(2):211–20. Available from: http://dx.doi.org/10.1016/j.iccl.2015.12.006
9. Sajadian M, Alizadeh L, Ganjifard M, Mardani A, Ansari MA, Falsoleiman H. Factors Affecting In-stent Restenosis in Patients Undergoing Percutaneous Coronary Angioplasty GMJ. Gmj [Internet]. 2018;7:961. Available from: www.gmj.irhttp://creativecommons.org/licenses/by/4.0/
10. Marino BCA, Nascimento GA, Rabelo W, Marino MA, Marino RL, Ribeiro ALP. Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes. Arq Bras Cardiol. 2015;104(5):375–86.
11. Kang SJ, Mintz GS, Park DW, Lee SW, Kim YH, Lee CW, et al. Mechanisms of in-stent restenosis after drug-eluting stent implantation intravascular ultrasound analysis. Circ Cardiovasc Interv. 2011;4(1):9–14.
12. Mitra AK, Agrawal DK. In stent Restenosis: Bane of the Stent Era. J Clin Pathol. 2006;59(3):232–9.
13. Maas AHEM, Appelman YEA. Gender differences in coronary heart disease. Netherlands Hear J. 2010;18(12):598–603.
14. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):1–12.
15. Pathak LA, Shirodkar S, Ruparelia R, Rajebahadur J. Coronary artery disease in women. Indian Heart J [Internet]. 2017;69(4):532–8. Available from: http://dx.doi.org/10.1016/j.ihj.2017.05.023
16. Eugenmed T, Clinical C, Group S, Regitz-zagrosek V, Oertelt-prigione S, Prescott E, et al. Gender in cardiovascular diseases?: impact on clinical manifestations , management , and outcomes. 2016;24–34.
17. Ashley E, Niebaur J. Coronary artery disease. In: Cardiology Explained. 2004.
18. Dhingra R, Vasan RS. Age As a Risk Factor. Med Clin North Am. 2012;96(1):87–91.
19. North BJ, Sinclair DA. The Intersection Between Aging and Cardiovascular Disease. Circ Res. 2012;110(8):1097–108.
20. Brown JC, Gerhardt TE, Kwon E. Risk Factors for Coronary Artery Disease. Statpearls. 2020;
21. Hussain MA, Mamun A Al, Peters SAE, Woodward M, Huxley RR. The burden of cardiovascular disease attributable to major modifiable risk factors in Indonesia. J Epidemiol. 2016;26(10):515–21.
22. Maharani A, Sujarwoto, Praveen D, Oceandy D, Tampubolon G, Patel A. Cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in Indonesia: The SMARThealth Extend study. PLoS One. 2019;14(4):1–13.
23. Kapoor R, Vyas S, Patel P, Mehta H, Mehta P, Modi J, et al. Short Communication A case-control study of risk factors for ischemic heart disease in patients attending tertiary care hospitals in India. 2013;3(1):57–60.
24. Djafri D, Monalisa, Elytha F, Machmud R. Efek modifikasi faktor risiko modifiable penyakit jantung koroner: a hospital-based matched case control study. J Kesehat Masy Andalas. 2017;11(2):93–9.
25. Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246.
26. Mazin I, Paul G, Asher E. Neoatherosclerosis – From basic concept to clinical implication. Thromb Res [Internet]. 2019;178(July 2018):12–6. Available from: https://doi.org/10.1016/j.thromres.2019.03.016
27. Bhatt DL. Percutaneous coronary intervention in 2018. JAMA - J Am Med Assoc. 2018;319(20):2127–8.
28. Mehilli J, Kastrati A, Bollwein H, Dibra A, Schühlen H, Dirschinger J, et al. Gender and restenosis after coronary artery stenting. Eur Heart J. 2003;24(16):1523–30.
29. Yamaji K, Shiomi H, Morimoto T, Toyota T, Ono K, Furukawa Y, et al. Influence of sex on long-term outcomes after implantation of bare-metal stent a multicenter report from the coronary revascularization demonstrating outcome study-kyoto (CREDO-Kyoto) registry cohort-1. Circulation. 2015;132(24):2323–33.
30. Regueiro A, Fernández-Rodríguez D, Brugaletta S, Martín-Yuste V, Masotti M, Freixa X, et al. Sex-related Impact on Clinical Outcome of Everolimus-eluting Versus Bare-metal Stents in ST-segment Myocardial Infarction. Insights From the EXAMINATION Trial. Rev Española Cardiol (English Ed. 2015;68(5):382–9.
31. Cho JY. Identification of Risk Factors Influencing In-Stent Restenosis with Acute Coronary Syndrome Presentation. Chonnam Med J. 2017;53(3):203.
32. Tang L, Cui QW, Liu DP, Fu YY. The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention. Med (United States). 2019;98(50):1–7.
33. Mohan S, Dhall A. A comparative study of restenosis rates in bare metal and drug-eluting stents. Int J Angiol. 2010;19(2).
34. Ogobuiro I, Wehrle CJ, Tuma F. Anatomy , Thorax , Heart Pulmonary Arteries Blood Supply and Lymphatics. Statpearls. 2020.
35. Weber C, Brown KN, Borger J. Anatomy, Thorax, Heart Anomalous Left Anterior Descending (LAD) Artery [Internet]. StatPearls. 2020. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30844189
36. Wihanda D, Alwi I, Yamin M, Shatri H, Mudjaddid E. Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention. Acta Med Indones. 2015;47(3):209–15.
37. Calais F, Lagerqvist B, Leppert J, James SK, Fröbert O. Proximal coronary artery intervention: Stent thrombosis, restenosis and death. Int J Cardiol [Internet]. 2013;170(2):227–32. Available from: http://dx.doi.org/10.1016/j.ijcard.2013.10.060
38. Schmidt W, Lanzer P, Behrens P, Brandt-Wunderlich C, Öner A, Ince H, et al. Direct comparison of coronary bare metal vs. drug-eluting stents: Same platform, different mechanics? Eur J Med Res [Internet]. 2018;23(1):1–12. Available from: https://doi.org/10.1186/s40001-017-0300-y
Unduhan
Diterbitkan
2021-04-03
Cara Mengutip
Zikriyya Melati Rahmany, Pintaningrum, Y., & Ermawan, R. (2021). HUBUNGAN LAMA IMPLANTASI STENT DENGAN KEJADIAN IN-STENT RESTENOSIS BERMAKNA PADA PASIEN PJK YANG DILAKUKAN ANGIOGRAFI KORONER EVALUASI DI RUMAH SAKIT UMUM DAERAH PROVINSI NUSA TENGGARA BARAT. Baphomet University : Situs Slot Online Gacor Terbaik Hari Ini Server Thailand Gampang Maxwin 2024, 10(1), 355–363. https://doi.org/10.29303/jku.v10i1.477
Terbitan
Bagian
Penelitian
